Quantification of cytomegalovirus viral load

References

• Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009;22:76-98
   PubMed Web of Science ®Google Scholar
• Varani S, Landini MP. Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae 2011;2:6
   PubMedGoogle Scholar
• Söderberg-Nauclér C. HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 2008;41:218-23
   PubMed Web of Science ®Google Scholar
• Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ. transplantation. Transplantation 2013;96:333-60
   PubMed Web of Science ®Google Scholar
• Solana R, Tarazona R, Aiello AE, et al. CMV and immunosenescence: from basics to clinics. Immun. Ageing A 2012;9:23
   PubMedGoogle Scholar
• Sloma CR, Grys TE, Razonable RR. Cytomegalovirus. In: Hayde RT, Carrol KC, Tang YW, Wolk DM, editors. Diagnostic microbiology of the immunocompromised host. ASM press; Washington, DC, USA: 2009. p. 69-89
   Google Scholar
• Razonable RR, Humar A; AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant 2013;13:93-106
   PubMed Web of Science ®Google Scholar
• Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998;11:533-54
   PubMed Web of Science ®Google Scholar
• Gerna G, Lilleri D, Furione M, Baldanti F. Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol 2011;34:229-54
   PubMed Web of Science ®Google Scholar
• Mazeron MC, Colimon R, Roseto A, Perol Y. Detection of cytomegaloviremia using monoclonal antibodies. Dev Biol Stand 1984;57:287-91
   PubMedGoogle Scholar
• Le Page AK, Jager MM, Kotton CN, et al. International survey of cytomegalovirus management in solid organ transplantation after the publication of consensus guidelines. Transplantation 2013;95:1455-60
   PubMed Web of Science ®Google Scholar
• Van der Bij W, Schirm J, Torensma R, et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1988;26:2531-5
   PubMed Web of Science ®Google Scholar
• Van der Bij W, Torensma R, van Son WJ, et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 1988;25:179-88
   PubMed Web of Science ®Google Scholar
• Gerna G, Lilleri D. Monitoring transplant patients for human cytomegalovirus: diagnostic update. Herpes J 2006;13:4-11
   PubMedGoogle Scholar
• Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009;113:5711-19
   PubMed Web of Science ®Google Scholar
• Kraft CS, Armstrong WS, Caliendo AM. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis 2012;54:1793-7
   PubMed Web of Science ®Google Scholar
• Razonable RR, Brown RA, Wilson J, et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 2002;73:968-73
   PubMed Web of Science ®Google Scholar
• Weinberg A, Schissel D, Giller R. Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients. J Clin Microbiol 2002;40:4203-6
   PubMedGoogle Scholar
• Pellegrin I, Garrigue I, Ekouevi D, et al. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J Infect Dis 2000;182:36-42
   PubMedGoogle Scholar
• Sanchez JL, Storch GA. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol 2002;40:2381-6
   PubMedGoogle Scholar
• Schäfer P, Tenschert W, Schröter M, et al. False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation. J Clin Microbiol 2000;38:3249-53
   PubMedGoogle Scholar
• Nesbitt SE, Cook L, Jerome KR. Cytomegalovirus quantitation by real-time PCR is unaffected by delayed separation of plasma from whole blood. J Clin Microbiol 2004;42:1296-7
   PubMedGoogle Scholar
• Abdul-Ali D, Kraft CS, Ingersoll J, et al. Cytomegalovirus DNA stability in EDTA anti-coagulated whole blood and plasma samples. J Clin Virol 2011;52:222-4
   PubMedGoogle Scholar
• Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993;56:330-4
   PubMedGoogle Scholar
• Bravo D, Clari MÁ, Costa E, et al. Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available Real-Time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Clin Microbiol 2011;49:2899-904
   PubMed Web of Science ®Google Scholar
• Cortez KJ, Fischer SH, Fahle GA, et al. Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. J Infect Dis 2003;188:967-72
   PubMed Web of Science ®Google Scholar
• Lisboa LF, Asberg A, Kumar D, et al. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011;91:231-6
   PubMed Web of Science ®Google Scholar
• Garrigue I, Doussau A, Asselineau J, et al. Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients. J Clin Microbiol 2008;46:493-8
   PubMed Web of Science ®Google Scholar
• Deback C, Fillet AM, Dhedin N, et al. Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood. J Clin Virol 2007;40:173-9
   PubMedGoogle Scholar
• Garrigue I, Boucher S, Couzi L, et al. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J Clin Virol 2006;36:72-5
   PubMed Web of Science ®Google Scholar
• Mengelle C, Sandres-Sauné K, Pasquier C, et al. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol 2003;41:3840-5
   PubMedGoogle Scholar
• Boeckh M, Huang M, Ferrenberg J, et al. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol 2004;42:1142-8
   PubMed Web of Science ®Google Scholar
• Waggoner J, Ho DY, Libiran P, Pinsky BA. Clinical significance of low cytomegalovirus DNA levels in human plasma. J Clin Microbiol 2012;50:2378-83
   PubMedGoogle Scholar
• Erice A, Tierney C, Hirsch M, et al. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis 2003;37:567-78
   PubMed Web of Science ®Google Scholar
• Forman M, Wilson A, Valsamakis A. Cytomegalovirus DNA quantification using an automated platform for nucleic Acid extraction and real-time PCR assay setup. J Clin Microbiol 2011;49:2703-5
   PubMedGoogle Scholar
• Wada K, Kubota N, Ito Y, et al. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol 2007;45:1426-32
   PubMed Web of Science ®Google Scholar
• Schönberger S, Meisel R, Adams O, et al. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010;16:1428-35
   PubMed Web of Science ®Google Scholar
• Yamane A, Mori T, Suzuki S, et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007;13:100-6
   PubMed Web of Science ®Google Scholar
• Deback C, Géli J, Aït-Arkoub Z, et al. Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: evaluation on whole blood specimens and proficiency panels. J Virol Methods 2009;159:291-4
   PubMedGoogle Scholar
• Laus S, Kingsley LA, Green M, Wadowsky RM. Comparison of QIAsymphony automated and QIAamp manual DNA extraction systems for measuring Epstein-Barr virus DNA load in whole blood using real-time PCR. J Mol Diagn 2011;13:695-700
   PubMedGoogle Scholar
• Germi R, Lupo J, Semenova T, et al. Comparison of commercial extraction systems and PCR assays for quantification of Epstein-Barr virus DNA load in whole blood. J Clin Microbiol 2012;50:1384-9
   PubMedGoogle Scholar
• Deback C, Agbalika F, Scieux C, et al. Detection of human herpesviruses HHV-6, HHV-7 and HHV-8 in whole blood by real-time PCR using the new CMV, HHV-6, 7, 8 R-gene kit. J Virol Methods 2008;149:285-91
   PubMedGoogle Scholar
• Kullberg-Lindh C, Olofsson S, Brune M, Lindh M. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA. Transpl Infect Dis 2008;10:308-15
   PubMed Web of Science ®Google Scholar
• Humar A, Asberg A, Kumar D, et al. An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes. Am J Transplant 2009;9:374-81
   PubMed Web of Science ®Google Scholar
• Ljungman P, de la Camara R, Cordonnier C, et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008;42:227-40
   PubMed Web of Science ®Google Scholar
• Bressollette-Bodin C, Coste-Burel M, Besse B, et al. Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy. J Med Virol 2009;81:90-8
   PubMedGoogle Scholar
• Barbi M, MacKay WG, Binda S, van Loon AM. External quality assessment of cytomegalovirus DNA detection on dried blood spots. BMC Microbiol 2008;8:2
   PubMedGoogle Scholar
• Leruez-Ville M, Ngin S, Guilleminot T, et al. Detection of cytomegalovirus DNA on dried blood spots collected from infants infected with HIV: an in-house method adaptable in resource-limited settings. J Virol Methods 2013;193:503-7
   PubMedGoogle Scholar
• Limaye AP, Santo Hayes TK, Huang M-L, et al. Quantitation of cytomegalovirus DNA load in dried blood spots correlates well with plasma viral load. J Clin Microbiol 2013;51:2360-4
   PubMed Web of Science ®Google Scholar
• Brantsæter AB, Johannessen A, Holberg-Petersen M, et al. Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania. Int J Infect Dis 2012;16:e879-85
   PubMed Web of Science ®Google Scholar
• Pillet S, Pozzetto B, Jarlot C, et al. Management of cytomegalovirus infection in inflammatory bowel diseases. Dig Liver Dis 2012;44:541-8
   PubMedGoogle Scholar
• Gerna G, Lilleri D, Furione M, et al. Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients. New Microbiol 2012;35:279-87
   PubMed Web of Science ®Google Scholar
• Bauer CC, Jaksch P, Aberle SW, et al. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 2007;45:324-8
   PubMed Web of Science ®Google Scholar
• Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 2011;106:2001-8
   PubMed Web of Science ®Google Scholar
• Pillet S, Bourlet T, Pozzetto B. Comparative evaluation of a commercially available automated system for extraction of viral DNA from whole blood: application to monitoring of Epstein-Barr virus and cytomegalovirus load. J Clin Microbiol 2009;47:3753-5
   PubMedGoogle Scholar
• Edelmann A, Eichenlaub U, Lepek S, et al. Performance of the MagNA Pure 96 system for cytomegalovirus nucleic acid amplification testing in clinical samples. J Clin Microbiol 2013;51:1600-1
   PubMedGoogle Scholar
• Verheyen J, Kaiser R, Bozic M, et al. Extraction of viral nucleic acids: comparison of five automated nucleic acid extraction platforms. J Clin Virol 2012;54:255-9
   PubMedGoogle Scholar
• Miller S, Seet H, Khan Y, et al. Comparison of QIAGEN automated nucleic acid extraction methods for CMV quantitative PCR testing. Am J Clin Pathol 2010;133:558-63
   PubMedGoogle Scholar
• Kerschner H, Bauer C, Schlag P, et al. Clinical evaluation of a fully automated CMV PCR assay. J Clin Virol 2011;50:281-6
   PubMed Web of Science ®Google Scholar
• Mengelle C, Mansuy J-M, Da Silva I, et al. Comparison of 2 highly automated nucleic acid extraction systems for quantitation of human cytomegalovirus in whole blood. Diagn Microbiol Infect Dis 2011;69:161-6
   PubMedGoogle Scholar
• Hanson KE, Reller LB, Kurtzberg J, et al. Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients. J Clin Microbiol 2007;45:1972-3
   PubMed Web of Science ®Google Scholar
• Caliendo AM, Yen-Lieberman B, Baptista J, et al. Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA. J Clin Microbiol 2003;41:3509-13
   PubMedGoogle Scholar
• Caliendo AM, Ingersoll J, Fox-Canale AM, et al. Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification. J Clin Microbiol 2007;45:1723-7
   PubMed Web of Science ®Google Scholar
• Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006;19:165-256
   PubMed Web of Science ®Google Scholar
• Mannonen L, Loginov R, Helanterä I, et al. Comparison of two quantitative real-time CMV-PCR tests calibrated against the 1st WHO international standard for viral load monitoring of renal transplant patients. J Med Virol 2013; Epub ahead of print
   PubMedGoogle Scholar
• Rabenau HF, Kessler HH, Kortenbusch M, et al. Verification and validation of diagnostic laboratory tests in clinical virology. J Clin Virol 2007;40:93-8
   PubMed Web of Science ®Google Scholar
• Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev 2010;23:550-76
   PubMed Web of Science ®Google Scholar
• Michelin BDA, Hadzisejdic I, Bozic M, et al. Detection of cytomegalovirus (CMV) DNA in EDTA whole-blood samples: evaluation of the quantitative artus CMV LightCycler PCR kit in conjunction with automated sample preparation. J Clin Microbiol 2008;46:1241-5
   PubMedGoogle Scholar
• Gouarin S, Vabret A, Scieux C, et al. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. J Virol Methods 2007;146:147-54
   PubMedGoogle Scholar
• Hardie DR, Korsman SNJ, Hsiao N-Y. Cytomegalovirus load in whole blood is more reliable for predicting and assessing CMV disease than pp65 antigenaemia. J Virol Methods 2013;193:166-8
   PubMed Web of Science ®Google Scholar
• Costa C, Mantovani S, Balloco C, et al. Comparison of two nucleic acid extraction and testing systems for HCMV-DNA detection and quantitation on whole blood specimens from transplant patients. J Virol Methods 2013;193:579-82
   PubMedGoogle Scholar
• Halfon P, Berger P, Khiri H, et al. Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation. J Med Virol 2011;83:490-5
   PubMed Web of Science ®Google Scholar
• Pillet S, Bourlet T, Pozzetto B. Comparative evaluation of the QIAsymphony RGQ system with the easyMAG/R-gene combination for the quantitation of cytomegalovirus DNA load in whole blood. Virol J 2012;9:231
   PubMedGoogle Scholar
• Raggam RB, Bozic M, Salzer HJF, et al. Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR. Med Microbiol Immunol 2010;199:311-16
   PubMedGoogle Scholar
• Hirsch HH, Lautenschlager I, Pinsky BA, et al. An international multicenter performance analysis of cytomegalovirus load tests. Clin Infect Dis 2013;56:367-73
   PubMed Web of Science ®Google Scholar
• Lee AV, Atkinson C, Manuel RJ, Clark DA. Comparative evaluation of the QIAGEN QIAsymphony® SP system and bioMérieux NucliSens easyMAG automated extraction platforms in a clinical virology laboratory. J Clin Virol 2011;52:339-43
   PubMedGoogle Scholar
• Pang XL, Fox JD, Fenton JM, et al. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009;9:258-68
   PubMed Web of Science ®Google Scholar
• Hayden RT, Yan X, Wick MT, et al. Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis. J Clin Microbiol 2012;50:337-45
   PubMed Web of Science ®Google Scholar
• Wolff DJ, Heaney DL, Neuwald PD, et al. Multi-Site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology. J Mol Diagn 2009;11:87-92
   PubMedGoogle Scholar
• Lilleri D, Lazzarotto T, Ghisetti V, et al. Multicenter quality control study for human cytomegalovirus DNAemia quantification. New Microbiol 2009;32:245-53
   PubMed Web of Science ®Google Scholar
• Caliendo AM, Shahbazian MD, Schaper C, et al. A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin Chem 2009;55:1701-10
   PubMedGoogle Scholar
• Schnepf N, Scieux C, Resche-Riggon M, et al. Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard. J Clin Microbiol 2013;51:2096-102
   PubMedGoogle Scholar
• Gracia-Ahufinger I, Tormo N, Espigado I, et al. Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays. J Clin Virol 2010;48:142-6
   PubMedGoogle Scholar
• Mengelle C, Mansuy J-M, Sauné K, et al. A new highly automated extraction system for quantitative real-time PCRs from whole blood samples: routine monitoring of opportunistic infections in immunosuppressed patients. J Clin Virol 2012;53:314-19
   PubMedGoogle Scholar
• Grys TE, Duquette DL, White B, et al. Precision across the analytical measuring range of a quantitative real-time PCR assay for cytomegalovirus detection among three clinical laboratories. J Clin Microbiol 2011;49:3044-6
   PubMedGoogle Scholar
• Muñoz-Cobo B, Solano C, Costa E, et al. Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies. Biol Blood Marrow Transplant 2011;17:1602-11
   PubMedGoogle Scholar
• Atabani SF, Smith C, Atkinson C, et al. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant 2012;12:2457-64
   PubMedGoogle Scholar
• Zweygberg Wirgart B, Brytting M, Linde A, et al. Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J Clin Microbiol 1998;36:3662-9
   PubMedGoogle Scholar
• Nye MB, Leman AR, Meyer ME, et al. Sequence diversity in the glycoprotein B gene complicates real-time PCR assays for detection and quantification of cytomegalovirus. J Clin Microbiol 2005;43:4968-71
   PubMed Web of Science ®Google Scholar
• Lengerova M, Racil Z, Volfova P, et al. Real-time PCR diagnostics failure caused by nucleotide variability within exon 4 of the human cytomegalovirus major immediate-early gene. J Clin Microbiol 2007;45:1042-4
   PubMedGoogle Scholar
• Novak Z, Chowdhury N, Ross SA, et al. Diagnostic consequences of cytomegalovirus glycoprotein B polymorphisms. J Clin Microbiol 2011;49:3033-5
   PubMedGoogle Scholar
• Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999;68:1305-11
   PubMed Web of Science ®Google Scholar
• Emery VC, Sabin CA, Cope AV, et al. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000;355:2032-6
   PubMed Web of Science ®Google Scholar
• Caliendo AM, St George K, Kao SY, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol 2000;38:2122-7
   PubMedGoogle Scholar
• Hantz S, Garnier-Geoffroy F, Mazeron M-C, et al. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother 2010;65:2628-40
   PubMed Web of Science ®Google Scholar
• Snydman DR, Limaye AP, Potena L, Zamora MR. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc 2011;43:S1-17
   PubMed Web of Science ®Google Scholar
• Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005;5:218-27
   PubMed Web of Science ®Google Scholar
• Fryer JF, Minor PD. Standardisation of nucleic acid amplification assays used in clinical diagnostics: a report of the first meeting of the SoGAT Clinical Diagnostics Working Group. J Clin Virol 2009;44:103-5
   PubMedGoogle Scholar
• Freyer JF, Heath AB, Anderson R, Minor PD. Collaborative Study Group. Collaborative study to evaluate the proposed 1st WHO International Standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. WHO/BS/10.2138. WHO; Geneva, Switzerland: 2010. p. 1-40
   Google Scholar
• Furione M, Rognoni V, Cabano E, Baldanti F. Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. J Clin Virol 2012;55:317-22
   PubMedGoogle Scholar
• Clari MÁ, Bravo D, Costa E, et al. Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia. Diagn Microbiol Infect Dis 2013;75:207-9
   PubMed Web of Science ®Google Scholar
• Pritt BS, Germer JJ, Gomez-Urena E, et al. Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV Test for management of CMV disease in transplant recipients. Diagn Microbiol Infect Dis 2013;75:440-2
   PubMedGoogle Scholar
• Hayden RT, Shahbazian MD, Valsamakis A, et al. Multicenter evaluation of a commercial cytomegalovirus quantitative standard: effects of commutability on interlaboratory concordance. J Clin Microbiol 2013;51:3811-17
   PubMed Web of Science ®Google Scholar
• Martín-Gandul C, Pérez-Romero P, Sánchez M, et al. Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection. J Clin Virol 2013;56:13-18
   PubMed Web of Science ®Google Scholar
• Razonable RR, Åsberg A, Rollag H, et al. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the world health organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis 2013;56:1546-53
   PubMed Web of Science ®Google Scholar
• Fishman JA, Emery V, Freeman R, et al. Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant 2007;21:149-58
   PubMed Web of Science ®Google Scholar
• Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev 2013;26:703-27
   PubMed Web of Science ®Google Scholar
• Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002;186:829-33
   PubMed Web of Science ®Google Scholar
• Buyck HCE, Griffiths PD, Emery VC. Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy. J Clin Virol 2010;49:32-6
   PubMed Web of Science ®Google Scholar
• Wittkop L, Bitard J, Lazaro E, et al. Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort. J Infect Dis 2013;207:622-7
   PubMed Web of Science ®Google Scholar
• Owers DS, Webster AC, Strippoli GFM, et al. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2013;2:CD005133
   Google Scholar
• Hodson EM, Ladhani M, Webster AC, et al. Cytomegalovirus-induced immunopathology and its clinical consequences. Cochrane Database Syst Rev 2013;2:CD003774
   Google Scholar
• Scott GM, Naing Z, Pavlovic J, et al. Viral factors influencing the outcome of human cytomegalovirus infection in liver transplant recipients. J Clin Virol 2011;51:229-33
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention, Infectious Diseases Society of America, American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6:659-713
   PubMed Web of Science ®Google Scholar
• Green ML, Leisenring W, Stachel D, et al. Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012;18:1687-99
   PubMedGoogle Scholar
• Wohl DA, Kendall MA, Andersen J, et al. Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. HIV Clin Trials 2009;10:143-52
   PubMed Web of Science ®Google Scholar
• Pellegrin I, Garrigue I, Binquet C, et al. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients. J Clin Microbiol 1999;37:3124-32
   PubMedGoogle Scholar
• Gentile G, Foà R. Viral infections associated with the clinical use of monoclonal antibodies. Clin Microbiol Infect 2011;17:1769-75
   PubMed Web of Science ®Google Scholar
• Uettwiller F, Rigal E, Hoarau C. Infections associated with monoclonal antibody and fusion protein therapy in humans. mAbs 2011;3:461-6
   PubMed Web of Science ®Google Scholar
• Manicklal S, Emery VC, Lazzarotto T, et al. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013;26:86-102
   PubMed Web of Science ®Google Scholar
• Revello MG, Fabbri E, Furione M, et al. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol 2011;50:303-7
   PubMed Web of Science ®Google Scholar
• Gouarin S, Palmer P, Cointe D, et al. Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR. J Clin Virol 2001;21:47-55
   PubMed Web of Science ®Google Scholar
• Ducroux A, Cherid S, Benachi A, et al. Evaluation of new commercial real-time PCR quantification assay for prenatal diagnosis of cytomegalovirus congenital infection. J Clin Microbiol 2008;46:2078-80
   PubMed Web of Science ®Google Scholar
• Gouarin S, Gault E, Vabret A, et al. Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 2002;40:1767-72
   PubMed Web of Science ®Google Scholar
• Fabbri E, Revello MG, Furione M, et al. Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood. BJO 2011;118:448-56
   PubMed Web of Science ®Google Scholar
• Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 2011;21:240-55
   PubMed Web of Science ®Google Scholar
• Boppana SB, Fowler KB, Pass RF, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005;146:817-23
   PubMed Web of Science ®Google Scholar
• Boppana SB, Ross SA, Shimamura M, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011;364:2111-18
   PubMed Web of Science ®Google Scholar
• Vauloup-Fellous C, Ducroux A, Couloigner V, et al. Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol 2007;45:3804-6
   PubMed Web of Science ®Google Scholar
• Boppana SB, Ross SA, Novak Z, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 2010;303:1375-82
   PubMed Web of Science ®Google Scholar
• N’Guyen Y, Baumard S, Salmon JH, et al. Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from Crohn’s disease treated by azathioprine: a series of four cases. Inflamm Bowel Dis 2011;17:E116-18
   Google Scholar
• Sinzger C, Grefte A, Plachter B, et al. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995;76:741-50
   PubMed Web of Science ®Google Scholar
• Limaye AP, Boeckh M. CMV in critically ill patients: pathogen or bystander? Rev Med Virol 2010;20:372-9
   PubMed Web of Science ®Google Scholar
• Chilet M, Aguilar G, Benet I, et al. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol 2010;82:1384-91
   PubMedGoogle Scholar
• Hayden RT, Gu Z, Ingersoll J, et al. Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus. J Clin Microbiol 2013;51:540-6
   PubMed Web of Science ®Google Scholar
• Ecker DJ, Sampath R, Massire C, et al. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008;6:553-8
   PubMed Web of Science ®Google Scholar
• Zürcher S, Mooser C, Lüthi AU, et al. Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysis. J Clin Virol 2012;54:359-63
   PubMedGoogle Scholar
• Legoff J, Feghoul L, Mercier-Delarue S, et al. Broad-range PCR-electrospray ionization mass spectrometry for detection and typing of adenovirus and other opportunistic viruses in stem cell transplant patients. J Clin Microbiol 2013;51:4186-92
   PubMed Web of Science ®Google Scholar
• Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLoS Biol 2006;4:e204
   PubMed Web of Science ®Google Scholar
• Njiru ZK. Loop-mediated isothermal amplification technology: towards point of care diagnostics. PLoS Negl Trop Dis 2012;6:e1572
   PubMed Web of Science ®Google Scholar
• Asiello PJ, Baeumner AJ. Miniaturized isothermal nucleic acid amplification, a review. Lab Chip 2011;11:1420-30
   PubMed Web of Science ®Google Scholar
• Gerna G, Baldanti F, Lilleri D, et al. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients. J Clin Microbiol 2000;38:1845-53
   PubMedGoogle Scholar
• Gozlan J, Salord JM, Chouaïd C, et al. Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. J Clin Microbiol 1993;31:1943-5
   PubMed Web of Science ®Google Scholar
• Gozlan J, Laporte JP, Lesage S, et al. Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J Clin Microbiol 1996;34:2085-8
   PubMedGoogle Scholar
• Hebart H, Lengerke C, Ljungman P, et al. Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT. Bone Marrow Transplant 2011;46:408-15
   PubMed Web of Science ®Google Scholar
• Meyer-Koenig U, Romberg I, Schneider K, et al. Diagnostic value of reverse transcription-PCR for detection of cytomegalovirus pp67 in samples from solid-organ transplant recipients. J Clin Microbiol 2006;44:3394-6
   PubMedGoogle Scholar
• Diaz-Mitoma F, Leger C, Miller H, et al. Comparison of DNA amplification, mRNA amplification, and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplant recipients. J Clin Microbiol 2003;41:5159-66
   PubMedGoogle Scholar
• Caliendo AM, St George K, Allega J, et al. Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays. J Clin Microbiol 2002;40:1581-6
   PubMedGoogle Scholar
• Humar A, Kumar D, Gray M, et al. A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection. Transplantation 2007;83:1200-6
   PubMedGoogle Scholar
• Emery VC, Manuel O, Asberg A, et al. Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy. J Clin Virol 2012;54:56-60
   PubMedGoogle Scholar
• Lisboa LF, Tong Y, Kumar D, et al. Analysis and clinical correlation of genetic variation in cytomegalovirus. Transpl Infect Dis 2012;14:132-40
   PubMed Web of Science ®Google Scholar
• Pang X, Humar A, Preiksaitis JK. Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J Clin Microbiol 2008;46:4004-10
   PubMedGoogle Scholar
• De Vries JJC, Wessels E, Korver AMH, et al. Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes. J Clin Microbiol 2012;50:232-7
   PubMedGoogle Scholar
• Clari MA, Aguilar G, Benet I, et al. Evaluation of cytomegalovirus (CMV)-specific t-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients. J Med Virol 2013;85:1802-10
   PubMedGoogle Scholar
• Griffiths P, Plotkin S, Mocarski E, et al. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 2013;31:B197-203
   PubMed Web of Science ®Google Scholar
• Kharfan-Dabaja MA, Boeckh M, Wilck MB, et al. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 2012;12:290-9
   PubMed Web of Science ®Google Scholar
• Mengelle C, Pasquier C, Rostaing L, et al. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Med Virol 2003;69:225-31
   PubMedGoogle Scholar
• Gouarin S, Vabret A, Gault E, et al. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay. J Clin Virol 2004;29:194-201
   PubMedGoogle Scholar
• Allice T, Enrietto M, Pittaluga F, et al. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test. J Med Virol 2006;78:915-22
   PubMedGoogle Scholar
• Cardeñoso L, Pinsky BA, Lautenschlager I, et al. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients. J Clin Virol 2013;56:108-12
   PubMed Web of Science ®Google Scholar
• Boaretti M, Sorrentino A, Zantedeschi C, et al. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients. J Clin Virol 2013;56:124-8
   PubMedGoogle Scholar
• Allice T, Cerutti F, Pittaluga F, et al. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment. J Virol Methods 2008;148:9-16
   PubMed Web of Science ®Google Scholar